Literature DB >> 26689117

A New Era of Innovation for CAR T-cell Therapy.

Robert M Frederickson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26689117      PMCID： PMC4700119          DOI： 10.1038/mt.2015.205

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  2 in total

Review 1.  Adoptive cellular therapy: a race to the finish line.

Authors:  Carl H June; Stanley R Riddell; Ton N Schumacher
Journal:  Sci Transl Med       Date:  2015-03-25       Impact factor: 17.956

2.  Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

Authors:  G Gross; T Waks; Z Eshhar
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205
  2 in total
  4 in total

Review 1.  Delivery technologies for genome editing.

Authors:  Hao Yin; Kevin J Kauffman; Daniel G Anderson
Journal:  Nat Rev Drug Discov       Date:  2017-03-24       Impact factor: 84.694

2.  A Perspective on the State of Genome Editing.

Authors:  Dana Carroll
Journal:  Mol Ther       Date:  2016-03       Impact factor: 11.454

3.  Genome editing: progress and challenges for medical applications.

Authors:  Dana Carroll
Journal:  Genome Med       Date:  2016-11-15       Impact factor: 11.117

Review 4.  Immuno-oncology trends: preclinical models, biomarkers, and clinical development.

Authors:  Maryland Rosenfeld Franklin; Suso Platero; Kamal S Saini; Giuseppe Curigliano; Steven Anderson
Journal:  J Immunother Cancer       Date:  2022-01       Impact factor: 13.751
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.